Business Description
Korean Drug Co Ltd
ISIN : KR7014570006
Compare
Compare
Traded in other countries / regions
014570.Korea IPO Date
2000-12-07Description
Korean Drug Co Ltd is engaged in manufacturing and marketing of pharmaceutical products in South Korea. Its products portfolio consists of over-the-counter (OTC) medicines, ethical (ETC) medicines and health food.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 278.52 | |||||
| Equity-to-Asset | 0.86 | |||||
| Debt-to-EBITDA | 0.02 | |||||
| Interest Coverage | 4677.15 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 4.92 | |||||
| Beneish M-Score | -1.95 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 7.1 | |||||
| 3-Year EBITDA Growth Rate | -1.6 | |||||
| 3-Year EPS without NRI Growth Rate | -25.1 | |||||
| 3-Year Book Growth Rate | 3.2 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 40.27 | |||||
| 9-Day RSI | 36.64 | |||||
| 14-Day RSI | 35.86 | |||||
| 6-1 Month Momentum % | -17.93 | |||||
| 12-1 Month Momentum % | -34.03 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.87 | |||||
| Quick Ratio | 4.63 | |||||
| Cash Ratio | 2.02 | |||||
| Days Inventory | 189.72 | |||||
| Days Sales Outstanding | 134.57 | |||||
| Days Payable | 35.57 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.29 | |||||
| Dividend Payout Ratio | 0.12 | |||||
| Forward Dividend Yield % | 3.29 | |||||
| 5-Year Yield-on-Cost % | 5.75 | |||||
| 3-Year Average Share Buyback Ratio | 0.3 | |||||
| Shareholder Yield % | 3.2 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 48.91 | |||||
| Operating Margin % | 22.13 | |||||
| Net Margin % | -0.52 | |||||
| FCF Margin % | -20.05 | |||||
| ROE % | -0.49 | |||||
| ROA % | -0.4 | |||||
| ROIC % | -8.37 | |||||
| ROC (Joel Greenblatt) % | 2.1 | |||||
| ROCE % | 1.43 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio without NRI | 3.68 | |||||
| PEG Ratio | 0.31 | |||||
| PS Ratio | 0.66 | |||||
| PB Ratio | 0.61 | |||||
| Price-to-Tangible-Book | 0.61 | |||||
| EV-to-EBIT | 24.69 | |||||
| EV-to-EBITDA | 9.02 | |||||
| EV-to-Revenue | 0.39 | |||||
| EV-to-FCF | -1.96 | |||||
| Price-to-Projected-FCF | 0.5 | |||||
| Price-to-DCF (Earnings Based) | 0.11 | |||||
| Price-to-Median-PS-Value | 0.49 | |||||
| Price-to-Graham-Number | 0.32 | |||||
| Price-to-Net-Current-Asset-Value | 0.89 | |||||
| Price-to-Net-Cash | 7.07 | |||||
| Earnings Yield (Greenblatt) % | 4.05 | |||||
| FCF Yield % | -30.3 | |||||
| Forward Rate of Return (Yacktman) % | 10.96 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Korean Drug Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 74,409.57 | ||
| EPS (TTM) (â‚©) | -35 | ||
| Beta | 0.63 | ||
| Volatility % | 12.03 | ||
| 14-Day RSI | 35.86 | ||
| 14-Day ATR (â‚©) | 118.407132 | ||
| 20-Day SMA (â‚©) | 4695.5 | ||
| 12-1 Month Momentum % | -34.03 | ||
| 52-Week Range (â‚©) | 4440 - 7980 | ||
| Shares Outstanding (Mil) | 10.8 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Korean Drug Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Korean Drug Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Korean Drug Co Ltd Frequently Asked Questions
What is Korean Drug Co Ltd(XKRX:014570)'s stock price today?
The current price of XKRX:014570 is â‚©4560.00. The 52 week high of XKRX:014570 is â‚©7980.00 and 52 week low is â‚©4440.00.
When is next earnings date of Korean Drug Co Ltd(XKRX:014570)?
The next earnings date of Korean Drug Co Ltd(XKRX:014570) is .
Does Korean Drug Co Ltd(XKRX:014570) pay dividends? If so, how much?
The Dividend Yield %  of Korean Drug Co Ltd(XKRX:014570) is 3.29% (As of Today), Highest Dividend Payout Ratio of Korean Drug Co Ltd(XKRX:014570) was 0.45. The lowest was 0.12. And the median was 0.25. The  Forward Dividend Yield % of Korean Drug Co Ltd(XKRX:014570) is 3.29%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers